Rossari Biotech Ltd

Rossari Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rossari Biotech Ltd

₹ 727 -1.07%
19 Apr - close price
rossari.com BSE: 543213 NSE : ROSSARI
About

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]

Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition

The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]

Key Points

Company Overview
Rossari Biotech is a Specialty-Chemicals manufacturer offering solutions for Home, Personal Care and Performance chemicals (HPPC), Textile specialty chemicals (TSC) and Animal Health and Nutrition (AHN). It offers a total of 4220+ products catering to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile, Performance Chemicals, Animal Health and Nutrition and Pet Care businesses. [1] [2]

Website BSE NSE
  • Market Cap ₹ 4,016 Cr.
  • Current Price ₹ 727
  • High / Low ₹ 904 / 657
  • Stock P/E 32.0
  • Book Value ₹ 177
  • Dividend Yield 0.07 %
  • ROCE 18.4 %
  • ROE 12.4 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last 3 years: -4.37%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
210 218 231 385 428 439 435 425 389 406 411 483 464
176 182 194 339 381 387 377 369 335 352 353 420 400
Operating Profit 34 36 37 46 48 52 58 57 54 55 58 64 64
OPM % 16% 17% 16% 12% 11% 12% 13% 13% 14% 13% 14% 13% 14%
1 2 3 2 6 3 1 1 1 3 2 1 4
Interest 0 1 1 2 5 5 5 8 5 4 6 5 4
Depreciation 6 7 6 10 16 17 15 16 16 16 14 15 15
Profit before tax 28 30 33 36 33 34 39 34 35 37 39 45 48
Tax % 24% 26% 26% 27% 30% 30% 26% 29% 26% 22% 26% 26% 28%
22 22 25 26 23 24 29 24 26 29 29 33 34
EPS in Rs 4.16 4.32 4.46 4.76 4.14 4.37 5.21 4.34 4.66 5.25 5.30 5.97 6.23
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
516 600 709 1,483 1,656 1,764
438 495 586 1,299 1,433 1,525
Operating Profit 78 105 124 184 223 240
OPM % 15% 17% 17% 12% 13% 14%
1 4 9 13 6 10
Interest 3 4 3 13 22 20
Depreciation 12 17 23 48 63 60
Profit before tax 63 88 107 136 144 169
Tax % 28% 26% 25% 28% 26%
46 65 80 98 107 126
EPS in Rs 103.82 12.86 15.45 17.74 19.45 22.75
Dividend Payout % 0% 4% 3% 3% 3%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 40%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 18%
TTM: 23%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -12%
1 Year: 6%
Return on Equity
10 Years: %
5 Years: %
3 Years: 16%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 4 10 10 11 11 11
Reserves 119 277 398 794 904 967
8 67 0 8 74 132
118 118 152 442 375 424
Total Liabilities 250 471 561 1,255 1,364 1,534
74 94 181 607 584 600
CWIP 3 22 0 1 16 24
Investments 0 18 0 36 51 24
173 338 379 611 714 885
Total Assets 250 471 561 1,255 1,364 1,534

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
71 57 48 29 152
-37 -190 -37 -299 -181
-29 157 -25 292 61
Net Cash Flow 5 23 -14 22 32

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 61 57 74 75 78
Inventory Days 59 57 75 63 59
Days Payable 114 95 104 61 58
Cash Conversion Cycle 6 19 46 76 79
Working Capital Days 25 39 60 64 58
ROCE % 38% 29% 24% 18%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
68.70% 68.56% 68.56% 68.56% 68.56% 68.46% 68.44% 68.44% 68.44% 68.35% 68.34% 68.32%
7.82% 8.46% 9.13% 9.03% 8.51% 8.84% 8.63% 7.46% 6.12% 5.74% 4.14% 4.02%
13.60% 12.87% 12.77% 12.29% 13.02% 14.15% 14.08% 15.09% 17.71% 17.68% 18.06% 17.74%
9.88% 10.10% 9.54% 10.12% 9.91% 8.55% 8.85% 9.01% 7.73% 8.23% 9.45% 9.90%
No. of Shareholders 49,32465,83176,49492,09998,56595,66497,08196,63495,37195,2001,00,42398,859

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls